Biotechnology
Orca Bio is a late-stage biotechnology company focused on redefining the transplant process by developing next-generation cell therapies for blood cancer patients. The company is addressing the limitations of traditional allogeneic stem cell transplants, which can be fatal or cause serious conditions like graft versus host disease. Orca Bio's purified, high-precision investigational cell therapies aim to replace patients' blood and immune systems with healthy ones while dramatically reducing risks and improving survival rates. With their innovative approach to cell therapy, the company seeks to restore patients' lives by providing significantly better outcomes than conventional transplant methods.
Beta · Sourced from candidate reports
Be the first to share your experience with Orca Bio.
Your reply helps other candidates know what to expect.
